Influencing factors and model predictive analysis of the efficacy of adjuvant ¹³¹I therapy after DTC surgery - Top-Institutions - MDSpire

Influencing factors and model predictive analysis of the efficacy of adjuvant ¹³¹I therapy after DTC surgery

  • By

  • Honghong Pan

  • Mingming Zheng

  • Qian Su

  • July 10, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Tianjin Medical University Cancer Institute and Hospital
    Tianjin Medical University Cancer Institute and Hospital

    Tianjin, Tianjin

    Key Differentiators

    • Endocrinology

  • #2

    Institute of Oncology Ljubljana
    Institute of Oncology Ljubljana

    Ljubljana, Slovenia

    Key Differentiators

    • Endocrinology

  • #3

    University Medical Center Utrecht
    University Medical Center Utrecht

    Utrecht, Utrecht

    Key Differentiators

    • Endocrinology

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology

  • #5

    Tertiary Grade A medical facility in Taiyuan
    Tertiary Grade A medical facility in Taiyuan

    Taiyuan, Shanxi

    Key Differentiators

    • Endocrinology

Original Source(s)

Influencing factors and model predictive analysis of the efficacy of adjuvant ¹³¹I therapy after DTC surgery

  • by Honghong Pan, Mingming Zheng, Qian Su

  • July 10, 2026

Related Content

Integrative genomic profiling identifies MLPH as a candidate gene in prostate cancer

Development and internal validation of a radiomics-clinical combined model for predicting axillary pathological complete response in clinically node-positive breast cancer patients after neoadjuvant chemotherapy

Survival beyond treatment: patterns and determinants of disease-free survival in cervical cancer at a tertiary care center in India